LCDX Stock Overview

A medical technologies company, designs, develops, and markets imaging solutions that shows tissue at the cellular level in the United States. More details

LCDX fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Does not have a meaningful market cap ($857)

Latest financial reports are more than a year old

Shares are highly illiquid

My Notes

Capture your thoughts, links and company narrative

Caliber Imaging & Diagnostics, Inc. Competitors

Motus GI Holdings

OTCPK:MOTS

US$719.0

Lucira Health

OTCPK:LHDX.Q

US$4.2k

ThermoGenesis Holdings

OTCPK:THMO

US$11.1k

ViewRay

OTCPK:VRAY.Q

US$18.3k

Price History & Performance

Summary of share price highs, lows and changes for Caliber Imaging & Diagnostics
Historical stock prices
Current Share Price	US$0.0001
52 Week High	US$0.0002
52 Week Low	US$0.0001
Beta	0
1 Month Change	0%
3 Month Change	0%
1 Year Change	0%
3 Year Change	-50.00%
5 Year Change	-99.98%
Change since IPO	-100.00%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	LCDX	US Medical Equipment	US Market
7D	0%	1.6%	0.7%
1Y	0%	9.2%	23.9%

Return vs Industry: LCDX underperformed the US Medical Equipment industry which returned 9.5% over the past year.

Return vs Market: LCDX underperformed the US Market which returned 24.4% over the past year.

Price Volatility

Is LCDX's price volatile compared to industry and market?
LCDX volatility
LCDX Average Weekly Movement	n/a
Medical Equipment Industry Average Movement	8.5%
Market Average Movement	6.4%
10% most volatile stocks in US Market	18.7%
10% least volatile stocks in US Market	3.1%

Stable Share Price: LCDX's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine LCDX's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1991	n/a	L. Hone	www.caliberid.com

Caliber Imaging & Diagnostics, Inc., a medical technologies company, designs, develops, and markets imaging solutions that shows tissue at the cellular level in the United States. The company provides VivaScope 1500, a reflectance confocal imaging system that enables clinicians and researchers to capture confocal images that depict cellular structures of living tissue; and VivaScope 3000, a hand-held in vivo reflectance confocal microscope for skin imaging. It also offers VivaScan software to schedule patients for examinations, perform imaging examinations on one or more lesions during a visit, review, and report on images obtained during an examination, as well as VivaNet, a digital telepathology system.

Caliber Imaging & Diagnostics, Inc. Fundamentals Summary

How do Caliber Imaging & Diagnostics's earnings and revenue compare to its market cap?
LCDX fundamental statistics
Market cap	US$857.00
Earnings (TTM)	-US$6.25m
Revenue (TTM)	US$3.14m

0.0x

P/S Ratio

0.0x

P/E Ratio

Is LCDX overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
LCDX income statement (TTM)
Revenue	US$3.14m
Cost of Revenue	US$2.65m
Gross Profit	US$486.00k
Other Expenses	US$6.74m
Earnings	-US$6.25m

Last Reported Earnings

Mar 31, 2014

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did LCDX perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/01/08 09:14
End of Day Share Price	2025/01/06 00:00
Earnings	2014/03/31
Annual Earnings	2013/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Caliber Imaging & Diagnostics, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution